Nyxoah S.A. (NYXH)
NASDAQ: NYXH · IEX Real-Time Price · USD
8.35
+0.01 (0.12%)
At close: Jul 26, 2024, 3:15 PM
8.33
-0.02 (-0.24%)
After-hours: Jul 26, 2024, 4:00 PM EDT

Nyxoah Revenue

Nyxoah had revenue of 1.22M EUR in the quarter ending March 31, 2024, with 176.87% growth. This brings the company's revenue in the last twelve months to 5.13M, up 78.99% year-over-year. In the year 2023, Nyxoah had annual revenue of 4.35M with 40.99% growth.

Revenue (ttm)
5.13M EUR
Revenue Growth
+78.99%
P/S Ratio
51.97
Revenue / Employee
34,932 EUR
Employees
147
Market Cap
286.22M USD

Revenue Chart

* This company reports financials in EUR.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20234.35M1.26M40.99%
Dec 31, 20223.08M2.23M261.97%
Dec 31, 2021852.00K783.00K1,134.78%
Dec 31, 202069.00K--
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
MultiPlan 959.44M
Viemed Healthcare 194.05M
LifeMD 163.56M
Alimera Sciences 90.22M
Sanara MedTech 68.00M
Artiva Biotherapeutics 32.75M
Orchestra BioMed Holdings 2.22M
Inovio Pharmaceuticals 717.07K
Revenue Rankings